Docetaxel Carboplatin Trastuzumab
Links shared publicly online about this topic
Beyond the Abstract - Carboplatin plus paclitaxel therapy after docetaxel in men with ...: BERKELEY, CA (UroToday....
urotoday.com — “Beyond the Abstract - Carboplatin plus paclitaxel therapy after docetaxel in men with ...: BERKELEY, CA (UroToday....” View full resource at urotoday.com
Most Recently Shared on July 30, 2010 at 5:41 pm By:
Urology & Nephrology OW Health
Beyond the Abstract - Carboplatin plus paclitaxel therapy after docetaxel in men with ...: BERKELEY, CA (UroToday.... http://bit.ly/cNlcFr
Pertuzumab Plus Trastuzumab Plus Docetaxel for Metastatic Breast Cancer - OncologySTAT
oncologystat.com — “2011 Dec 7;[Epub Ahead of Print] - J Baselga, J Cortes, S-B Kim, S Swain, et al” View full resource at oncologystat.com
Most Recently Shared on December 15, 2011 at 8:35 pm By:
OncologySTAT Health Site and Oncology
Story of the Week: Pertuzumab Added to Trastuzumab/Docetaxel Benefits Metastatic Breast Cancer http://t.co/8eWoZuSG
Urology Article | Carboplatin Prostatic Neoplasms
mdlinx.com — “Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancer” View full resource at mdlinx.com
Most Recently Shared on July 18, 2011 at 9:46 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combin... http://bit.ly/p3o1Bz #urology
Oncology Article | Carboplatin Prostatic Neoplasms
mdlinx.com — “Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancer” View full resource at mdlinx.com
Most Recently Shared on June 29, 2011 at 7:28 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combi... http://bit.ly/mO87P5 #oncology
Regarding the medications you took, Carboplatin, Docetaxel, tamoxifen, & Herceptin. What do you wish your physician would have shared about these medications?
talkabouthealth.com — “I wish that my physician (who is no longer my physician) had explained the relationship between steroids (the reason for pre-medicating with steroids) and the c” View full resource at talkabouthealth.com
Most Recently Shared on September 22, 2011 at 8:47 pm By:
Regarding meds taken Carboplatin, Docetaxel. What do you wish physician shared abot them? grt ans @cancerfree2b http://t.co/ZXSc8QXZ #bcsm
Oncology Medical News about Breast Neoplasms Carboplatin
mdlinx.com — “Differential response of triple-negative breast cancer to a docetaxel and carboplatin-based neoadjuvant treatment” View full resource at mdlinx.com
Most Recently Shared on June 21, 2010 at 6:26 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Differential response of triple-negative breast cancer to a docetaxel and carboplatin-based neoadjuvant t... http://bit.ly/aWrk6B #oncology
Oncology Medical News about Carboplatin Head and Neck Neoplasms
mdlinx.com — “Carboplatin with weekly docetaxel and ifosfamide in advanced head and neck cancers: A phase I Brown University Oncology Group dose escalation study (HN-93)” View full resource at mdlinx.com
Most Recently Shared on February 11, 2010 at 12:55 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Oncology Carboplatin with weekly docetaxel and ifosfamide in advanced head and neck cancers: A phase I Brown Unive... http://bit.ly/agypR9
Would you share your experience taking trastuzumab (herceptin)? What were the side effects you experienced?
talkabouthealth.com — “Taking trastuzumab (herceptin) was no problem at all compared to the other drugs I was taking (carboplatin, taxotere). That said, the nurses told me that there” View full resource at talkabouthealth.com
Most Recently Shared on March 4, 2012 at 11:29 pm By:
Wld you share your experience taking #herceptin? What were side effects you experienced? http://t.co/GIlh9Eg9 #bcsm #breastcancer #cancer
Trastuzumab-DM1 Is Efficacious and Has a Good Safety Profile in Patients With Metastatic Breast Cancer - QualityPoint Technologies
qualitypointtech.net — “Compared with trastuzumab plus docetaxel, trastuzumab-DM1 has a significantly better adverse event profile in first-line treatment of metastatic breast cancer. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on October 9, 2010 at 7:12 pm By:
Trastuzumab-DM1 Is Efficacious and Has a Good Safety Profile in Patients With Metastatic Breast Cancer: Compared w... http://bit.ly/dhVnEI
Oncology Article | Breast Neoplasms
mdlinx.com — “Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: The HERNATA Study” View full resource at mdlinx.com
Most Recently Shared on December 15, 2010 at 8:27 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as f... http://bit.ly/ikowdy #oncology
Oncology Article | Ovarian Neoplasms
mdlinx.com — “Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum-sensitive, recurrent ovarian cancer” View full resource at mdlinx.com
Most Recently Shared on May 25, 2011 at 2:00 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of pla... http://bit.ly/lrNcEE #oncology
Oncology Medical News about Breast Neoplasms
mdlinx.com — “Phase II study of preoperative systemic treatment with the combination of docetaxel and trastuzumab in patients with locally advanced HER-2-overexpressing breast cancer” View full resource at mdlinx.com
Most Recently Shared on May 21, 2010 at 10:01 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Phase II study of preoperative systemic treatment with the combination of docetaxel and trastuzumab in pa... http://bit.ly/balQyM #oncology
Elsevier Global Medical News
egmn.idsk.com — “Elsevier Global Medical News” View full resource at egmn.idsk.com
Most Recently Shared on March 31, 2010 at 9:39 pm By:
Bob Finn - Medical News Net Health News
Combination Docetaxel and Carboplatin Trumps Sequential Therapy in Ovarian Cancer @hsplete reports http://bit.ly/aWBEW1
Dual HER2 Blockade Significantly Extends Progression-Free Survival
medicalnewstoday.com — “Adding pertuzumab to a combination of trastuzumab and docetaxel chemotherapy extended progression-free survival by a median of 6.1 months in patients with metastatic HER2-positive breast cancer co” View full resource at medicalnewstoday.com
Most Recently Shared on December 8, 2011 at 10:05 am By:
MNT Clinical Trials Health News
Dual HER2 Blockade Significantly Extends Progression-Free Survival http://t.co/KqS6Dzrd #clinicaltrials
Oncology Medical News about Lung cancer
mdlinx.com — “Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancer” View full resource at mdlinx.com
Most Recently Shared on March 30, 2010 at 7:26 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell... http://bit.ly/dy3fMT #HemeOnc
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Urology & Nephrology
Organizing urology resources shared by health experts, advocates, and organizations into WisdomCards.
-
OncologySTAT
Authoritative oncology information organized by cancer type for cancer specialists and professionals
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
